您的当前位置:首页 > 行业数据 > 全球用于HTG的临床开发中靶向APOC3的siRNA候选药物
图片属性
图片格式:PNG 图片大小:153KB 图片尺寸:2268*951
同报告图片
 / 4
全球用于HTG的临床开发中靶向APOC3的siRNA候选药物_第1页
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
全球用于HTG的临床开发中靶向APOC3的siRNA候选药物_第2页
全球用于HTG的临床开发中靶向APOC3的siRNA候选药物_第3页
全球用于HTG的临床开发中靶向APOC3的siRNA候选药物_第4页
全球用于HTG的临床开发中靶向APOC3的siRNA候选药物_第5页
所属报告: 瑞博生物~B-6938.HK-港股公司研究报告:中国小核酸创新药领军者增长潜力大-260409(32页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠